Long-Term Neuroprotection Achieved with Latency-Associated Promoter-Driven Herpes Simplex Virus Gene Transfer to the Peripheral Nervous System
Open Access
- 31 August 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (2), 307-313
- https://doi.org/10.1016/j.ymthe.2005.04.009
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Herpes Vector-Mediated Gene Transfer in Treatment of Diseases of the Nervous SystemAnnual Review of Microbiology, 2004
- Peripherally Delivered Glutamic Acid Decarboxylase Gene Therapy for Spinal Cord Injury PainMolecular Therapy, 2004
- Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathyBrain, 2004
- Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic painPain, 2003
- Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animalsEuropean Journal of Neuroscience, 2003
- Herpes vector–mediated expression of proenkephalin reduces bone cancer painAnnals of Neurology, 2002
- Herpes Simplex-Mediated Gene Transfer of Nerve Growth Factor Protects Against Peripheral Neuropathy in Streptozotocin-Induced Diabetes in the MouseDiabetes, 2002
- Bcl-2 and GDNF Delivered by HSV-Mediated Gene Transfer after Spinal Root Avulsion Provide a Synergistic EffectJournal of Neurotrauma, 2002
- Development and Optimization of Herpes Simplex Virus Vectors for Multiple Long-Term Gene Delivery to the Peripheral Nervous SystemJournal of Virology, 2000
- DEVELOPMENT AND APPLICATION OF HERPES SIMPLEX VIRUS VECTORS FOR HUMAN GENE THERAPYAnnual Review of Microbiology, 1995